OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
2.505
-0.115 (-4.39%)
Jun 3, 2026, 12:05 PM EDT - Market open
OmniAb Employees
OmniAb had 89 employees as of December 31, 2025. The number of employees decreased by 25 or -21.93% compared to the previous year.
Employees
89
Change (1Y)
-25
Growth (1Y)
-21.93%
Revenue / Employee
$325,157
Profits / Employee
-$609,955
Market Cap
363.16M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 89 | -25 | -21.93% |
| Dec 31, 2024 | 114 | 8 | 7.55% |
| Dec 31, 2023 | 106 | 11 | 11.58% |
| Dec 31, 2022 | 95 | 21 | 28.38% |
| Sep 30, 2022 | 93 | 23 | 32.86% |
| Jun 30, 2022 | 87 | 17 | 24.29% |
| Dec 31, 2021 | 74 | 4 | 5.71% |
| Sep 30, 2021 | 70 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| REGENXBIO | 371 |
| Enanta Pharmaceuticals | 120 |
| Artiva Biotherapeutics | 104 |
| Verastem | 102 |
| Prelude Therapeutics | 79 |
| Larimar Therapeutics | 71 |
| Rezolute | 68 |
OABI News
- 26 days ago - OmniAb reports Q1 EPS (6c), consensus (10c) - TheFly
- 26 days ago - OmniAb raises FY26 revenue view to $28M-$33M, consensus $28.0M - TheFly
- 26 days ago - OmniAb Earnings Call Transcript: Q1 2026 - Transcripts
- 26 days ago - OmniAb Slides: Q1 2026 - Filings
- 26 days ago - OmniAb Earnings release: Q1 2026 - Filings
- 26 days ago - OmniAb Quarterly report: Q1 2026 - Filings
- 26 days ago - OmniAb Reports First Quarter 2026 Financial Results and Business Highlights - Business Wire
- 5 weeks ago - OmniAb Proxy statement: Proxy filing - Filings